Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Evaluating the Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

NCT03948724 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT03948724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03948724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Evaluating the Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Not applicable
Overall status
Completed
Start date
December 11, 2019
Completion date
August 22, 2024
Enrollment
412 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-small cell lung cancer, head and neck cancer, immune checkpoint inhibitors, immune-related adverse event, melanoma, renal cell carcinoma, therapeutic patient education